 |
||||
|
||||
|
||||
|
||||
The Journal of Neuroscience, August 22, 2007, 27(34):9201-9219; doi:10.1523/JNEUROSCI.1470-07.2007
Previous Article | Next Article
Neurobiology of Disease
Microarray Analysis of the Cellular Pathways Involved in the Adaptation to and Progression of Motor Neuron Injury in the SOD1 G93A Mouse Model of Familial ALS
Laura Ferraiuolo, Paul R. Heath, Hazel Holden, Paul Kasher, Janine Kirby, andPamela J. Shaw Academic Neurology Unit, Section of Neuroscience, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield S10 2RX, United Kingdom
Correspondence should be addressed to Prof. Pamela J. Shaw, Academic Neurology Unit, E Floor, Medical School, Beech Hill Road, Sheffield S10 2 RX, UK. E-mail Email: pamela.shaw{at}sheffield.ac.uk
The cellular pathways of motor neuronal injury have been investigated in the SOD1 G93A murine model of familial amyotrophic lateral sclerosis (ALS) using laser-capture microdissection and microarray analysis. The advantages of this study include the following: analysis of changes specifically in motor neurons (MNs), while still detecting effects of interactions with neighboring cells; the ability to profile changes during disease progression, an approach not possible in human ALS; and the use of transgenic mice bred on a homogeneous genetic background, eliminating the confounding effects arising from a mixed genetic background. By using this rigorous approach, novel changes in key cellular pathways have been detected at both the presymptomatic and late stages, which have been validated by quantitative reverse transcription-PCR.
At the presymptomatic stage (60 d), MNs extracted from SOD1 G93A mice show a significant increase in expression of genes subserving both transcriptional and translational functions, as well as lipid and carbohydrate metabolism, mitochondrial preprotein translocation, and respiratory chain function, suggesting activation of a strong cellular adaptive response. Mice 90 d old still show upregulation of genes involved in carbohydrate metabolism, whereas transcription and mRNA processing genes begin to show downregulation. Late in the disease course (120 d), important findings include the following: marked transcriptional repression, with downregulation of multiple transcripts involved in transcriptional and metabolic functions; upregulation of complement system components; and increased expression of key cyclins involved in cell-cycle regulation. The changes described in the motor neuron transcriptome evolving during the disease course highlight potential novel targets for neuroprotective therapeutic intervention.
Key words: amyotrophic lateral sclerosis; microarray; laser-capture microdissection; transcriptome; motor neurons; clinical intervention
Received April 2, 2007; revised June 11, 2007; accepted June 21, 2007.
Correspondence should be addressed to Prof. Pamela J. Shaw, Academic Neurology Unit, E Floor, Medical School, Beech Hill Road, Sheffield S10 2 RX, UK. E-mail Email: pamela.shaw{at}sheffield.ac.uk
This article has been cited by other articles:
C. J McDermott and P. J Shaw
Diagnosis and management of motor neurone disease
BMJ, March 22, 2008; 336(7645): 658 - 662.
[Full Text] [PDF]
J.-L. Gonzalez de Aguilar, C. Niederhauser-Wiederkehr, B. Halter, M. De Tapia, F. Di Scala, P. Demougin, L. Dupuis, M. Primig, V. Meininger, and J.-P. Loeffler
Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model
Physiol Genomics, January 17, 2008; 32(2): 207 - 218.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|